N/A
N=149
The Relationship Between Vitamin D and Hepatitis B Virus Replication
Vitamin D and Hepatitis B Virus
Bottom Line
View on ClinicalTrials.gov: NCT03068767 ↗Enrolled (actual)
149
Serious AEs
0.0%
Results posted
Feb 2020
Primary outcome: Primary: The Dynamic Change of HBV DNA — 3.15; 3.14 IU/mL
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Vitamin D (Dietary_supplement)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Primary completion
- Jan 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Dynamic Change of HBV DNA |
3.15; 3.14 | — |
| PRIMARY The Change of Serum qHBsAg (IU/mL) |
2.19; 2.4 | — |
Summary
149 HBV carriers with inadequate serum vitamin D levels were randomized to two groups: one is supplied with vitamin D and another without as controls. The markers of HBV replication were compared before and after treatment.
Eligibility Criteria
Inclusion Criteria
- >20 y/o, HBV carrier
- serum vitamin D < 30ng/ml
Exclusion Criteria
- Other known causes of hepatitis
Data sourced from ClinicalTrials.gov (NCT03068767). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.